Helicobacter pylori quadruple drug can effectively eradicate Helicobacter pylori, and the eradication rate can reach 85%~94%.
Helicobacter pylori is a kind of bacteria parasitizing the human stomach, and its infection is closely related to the development of chronic gastritis, peptic ulcer, gastric cancer, etc. Generally speaking, when there is a positive Helicobacter pylori, timely eradication treatment is needed to reduce the incidence of gastric diseases.
At present, the most commonly used clinical method to eradicate H. pylori is quadruple therapy, which means one proton pump inhibitor (e.g., omeprazole, lansoprazole, etc.) + two antibiotics (amoxicillin, clarithromycin, metronidazole, etc.) + one bismuth agent (bismuth potassium citrate, bismuth pectin, etc.). The course of treatment is usually 14 days, and the eradication rate can reach 85% to 94%.
However, Helicobacter pylori may have adverse reactions such as nausea, loss of appetite, abdominal discomfort, black stools, etc. It should be used with caution by pregnant women, lactating women, and those with liver or kidney insufficiency, and it is also noted that alcohol consumption is strictly prohibited during the treatment period.
Generally speaking, 1 month after the end of the treatment of quadruple therapy, it is necessary to carry out Helicobacter pylori examination again to observe the eradication effect. The medication should be taken strictly according to the doctor’s prescription, and should not be self-administered to avoid causing serious adverse reactions.